Family Medicine Doctors in Marfa, TX Accepting Medicare
5 Family Medicine doctors found. Showing 1 - 5
 Dr. John Paul Schwartz, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 105 East Oak, Marfa, TX 79843 Phone: 432-729-3000 Fax: 432-729-3001 |
Adrian N Billings, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 210 S. Summer St., Marfa, TX 79843 Phone: 432-729-1800 Fax: 432-729-1806 |
 Katie Ray, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 406 South Summer Street, Marfa, TX 79843 Phone: 432-729-1812 Fax: 432-729-4023 |
Steven Seegers, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 217 North Summer St., Marfa, TX 79843 Phone: 432-729-4256 |
Dr. Marco Samuel Garcia, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 105 E Oak St, Marfa, TX 79843 Phone: 432-729-3000 Fax: 432-729-3001 |
News Archive
New research explores role of genes, environment in post-natal depression
New research involving the University of York explores the interplay between genes and environment when determining whether a mother is at high or low risk for post-natal depression.
Study reveals wide disparities in global adult mortality rates
The most comprehensive assessment to date of global adult mortality appears today, April 30, in The Lancet . The study, "Worldwide mortality in men and women aged 15-59 years from 1970 to 2010: a systematic analysis", shows that across countries, inequality in adult mortality has grown to the point where adult men in Swaziland - the country with the worst mortality rate - now have a probability of premature death that is nine times the mortality rate of the best country, Cyprus.
Eurotech enters multiple contracts with DynaVox for Catalyst embedded computers
Eurotech, a leading supplier of embedded technologies, products, and systems, today announces multiple contracts with DynaVox to deliver the Catalyst LP and Catalyst Module embedded computers for the DynaVox V, Vmax and Xpress™ alternative augmentative communication (AAC) devices. The combined value of these contracts is nearly 4.2M USD, with deliveries to be made in 2010 and 2011.
Gene therapy for common forms of congenital blindness shows promise to improve vision
A new gene therapy for one of the most common forms of congenital blindness was safe and improved patients' vision, according to initial data from a clinical trial led by researchers at the Scheie Eye Institute in the Perelman School of Medicine at the University of Pennsylvania.
› Verified 5 days ago